Impacting Pandemic Management
Our COVID-19 PCR system may help people around the world get rapid diagnostic results.
XPhyto and its exclusive development partner, 3a, are leading the development and production of a rapid, point-of-care PCT test system designed for use with minimal lab equipment and training. This enables deployment in community and industry sites such as pharmacies and airports.
“With no need for large, specialized laboratories, our system is particularly well suited for point-of-care testing. We believe this will provide increased speed, convenience and flexibility for the immediate identification of infected people in a wider variety of settings through the use of satellite and mobile labs,” says Hugh Rogers, CEO & Director of XPhyto.